Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03410719 · ClinicalTrials.gov registry record · NA

Mediterranean Style Diet and Low Glycemic Responses

A NA study of Insulin Sensitivity, sponsored by Purdue University.

Completed
Registry status
NA
Development phase
166
Enrollment target
1
Study location

NCT03410719 is a NA study of Insulin Sensitivity that has completed, run by Purdue University. The registered enrollment target is 166 participants, above the 67-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (148% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03410719, a NA study of Insulin Sensitivity, has completed, sponsored by Purdue University.

COMPLETED
Registry status
NA
Development phase
166 participants
Enrollment target
1
Study location

Study Summary

the aim of this study is to evaluate whether a Mediterranean diet rich in pasta and other starchy foods with a (Low-GI), as compared with a similar Mediterranean diet containing very little pasta and based on starchy foods with a (Hi-GI) is able to reduce insulin and glucose concentrations during a prolonged test study meal.

Conditions Studied

Interventions

  • OTHER Hi GI

Study Locations (1)

Indiana

  • Purdue University - West Lafayette

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2018-01-04
Est. Completion 2020-03-21
Phase NA

Sponsor

Purdue University

141 total trials

What the Registry Record Tells You About NCT03410719

The ClinicalTrials.gov registry entry for NCT03410719 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 67-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (148% higher). The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insulin Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Hi GI is the first listed.

NCT03410719 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT03410719 about?

NCT03410719 is a clinical study titled "Mediterranean Style Diet and Low Glycemic Responses". the aim of this study is to evaluate whether a Mediterranean diet rich in pasta and other starchy foods with a (Low-GI), as compared with a similar Mediterranean diet containing very little pasta and based on starchy foods with a (Hi-GI) is able to reduce insulin and glucose concentrations during a ...

What is the current status of trial NCT03410719?

This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2018-01-04. Estimated completion is 2020-03-21.

What conditions does trial NCT03410719 study?

This clinical trial studies the following conditions: Insulin Sensitivity.

What interventions are being tested in trial NCT03410719?

The interventions under investigation include: Hi GI (OTHER).

Who is sponsoring clinical trial NCT03410719?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03410719 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Sensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.